OptiNose’s (OPTN) Neutral Rating Reiterated at HC Wainwright
HC Wainwright restated their neutral rating on shares of OptiNose (NASDAQ:OPTN – Free Report) in a research report sent to investors on Friday morning, Marketbeat reports. The brokerage currently has a $9.00 target price on the stock, down from their previous target price of $18.00. Separately, Lake Street Capital downgraded shares of OptiNose from a […]
More Stories
Diebold Nixdorf (NYSE:DBD) Upgraded at Wedbush
Wedbush upgraded shares of Diebold Nixdorf (NYSE:DBD – Free Report) to a strong-buy rating in a research note issued to...
Lockheed Martin (NYSE:LMT) Price Target Lowered to $453.00 at UBS Group
Lockheed Martin (NYSE:LMT – Get Free Report) had its price target dropped by investment analysts at UBS Group from $498.00...
BHP Group (LON:BHP) Stock Rating Lowered by Berenberg Bank
BHP Group (LON:BHP – Get Free Report) was downgraded by analysts at Berenberg Bank from a “hold” rating to a...
Berenberg Bank Issues Pessimistic Forecast for Breedon Group (LON:BREE) Stock Price
Breedon Group (LON:BREE – Get Free Report) had its target price decreased by stock analysts at Berenberg Bank from GBX...
Canadian National Railway (TSE:CNR) Lowered to Hold Rating by Evercore ISI
Canadian National Railway (TSE:CNR – Get Free Report) (NYSE:CNI) was downgraded by stock analysts at Evercore ISI from a “strong-buy”...
Kalaris Therapeutics (NASDAQ:KLRS) Upgraded by Piper Sandler to Hold Rating
Kalaris Therapeutics (NASDAQ:KLRS – Get Free Report) was upgraded by equities researchers at Piper Sandler to a “hold” rating in...